Melinta Therapeutics: sNDA Acceptance Triggers 200% Gain [Seeking Alpha]
MELINTA THERAPEUTICS INC (MLNT)
Last melinta therapeutics inc earnings: 11/12 04:39 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.melinta.com/investor-relations
Company Research
Source: Seeking Alpha
Melinta Therapeutics: sNDA Acceptance Triggers 200% Gain Summary Melinta Therapeutics stock rockets as a result of BAXDELA's sNDA being accepted by the FDA for a priority review. The company was given a PDUFA date of October 24. This expedited review could set up to be a good trade and/or long-term hold. I provide some reasons to hold Melinta stock going into the PDUFA and potentially beyond. I review some of the major downside risks that investors need to be cognizant of when looking to enter a position in Melinta. On June 19 MLNT announced Jeffries analyst I intend to discuss whether or not this sNDA move was an overreaction. In addition, I provide a couple of reason why investors should hold their shares and also potential downside risks for those looking to enter at these prices. Image Source: Company Overview merged purchased Figure 1: Melinta Product (Source: ) Background BAXDELA BAXDELA (delafloxacin) is arguably the company’s flagship product due to its uses against both gram
Show less
Read more
Impact Snapshot
Event Time:
MLNT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MLNT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MLNT alerts
High impacting MELINTA THERAPEUTICS INC news events
Weekly update
A roundup of the hottest topics